Treatment with an adenosine uptake inhibitor attenuates glomerulonephritis in mice

European Journal of Pharmacology

Volumn 449, Issue 3, 2002, Pages 293-300

  Noji, Tohru ^a   Sato, Hitoshi ^a   Sano, Jun ichi ^a   Nishikawa, Satoshi ^a   Kusaka, Hideaki ^a   Karasawa, Akira ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Adenosine; Glomerulonephritis; KF24345

Indexed keywords

3 [1 (6,7 DIETHOXY 2 MORPHOLINOQUINAZOLIN 4 YL)PIPERIDIN 4 YL] 1,6 DIMETHYL 2,4(1H,3H) QUINAZOLINEDIONE; ADENOSINE UPTAKE INHIBITOR; ALANINE AMINOTRANSFERASE; BILIRUBIN; BLOCKING AGENT; CYCLOPHOSPHAMIDE; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; KF 24345; PREDNISOLONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; ENZYME BLOOD LEVEL; ERYTHROCYTE COUNT; GLOMERULONEPHRITIS; HISTOLOGY; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEINURIA; SPLEEN WEIGHT; THYMUS;

EID: 0037047669     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02039-3     Document Type: Article

References (33)

1. 2-receptor agonists on intrarenal blood flow
2. The control of the metabolism and the hormonal role of adenosine
3. The extracellular matrix in pathology
4. Interactive effects of tumor necrosis factor and platelet-activating factor in the pathogenesis of glomerular injury
5. Renal effects of selective adenosine receptor agonists in anesthetized rats
6. Adenosine receptor subtypes
7. A novel approach to the development of anti-inflammatory agents: Adenosine release at inflamed sites
8. Adenosine regulation of neutrophil function and inhibition of inflammation via adenosine receptors
9. The anti-inflammatory effects of an adenosine kinase inhibitor are mediated by adenosine
10. Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis
11. Nomenclature and classification of purinoceptors
12. A DNA element in the alpha1 type III collagen promoter mediates a stimulatory response by angiotensin II
13. Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis
14. Adenosine induced fall in glomerular capillary pressure. Effect of ureteral obstruction and aortic constriction in the Munich-Wistar rat kidney
15. Renal actions of purines
16. 5′-Nucleotidase as a marker of both general and local inflammation in rheumatoid arthritis patients
17. Inhibition of human monocyte TNF production by adenosine receptor agonists
18. Turnover of adenosine in plasma of human and dog blood
19. Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists
20. Experimental glomerulonephritis in mice as a model for immunopharmacological studies
21. KF24345, an adenosine uptake inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor-α production and leukopenia via endogenous adenosine in mice
22. Adenosine receptor subtypes: Characterization and therapeutic regulation
23. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis
24. Renal action of adenosine: Effect on renin secretion in the rat
25. Adenosine as a possible mediator of metabolic control of glomerular filtration rate
26. Modulation of anti-Thy1 nephritis in the rat by adenine nucleotides
27. Attenuation of anti-Thy1 glomerulonephritis in the rat by anti-inflammatory platelet-inhibiting agents
28. Receptors for purines and pyrimidines
29. Purinergic modulation of septic shock and systemic inflammation response syndrome
30. The anti-inflammatory effects of adenosine receptor agonists on the carrageenan-induced pleural inflammatory response in rats
31. Studies on the renal glomerular basement membrane
32. The concept of 'glomerulonephritis'
33. Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRγ-deficient mice